from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2308/-

LFCtreatmentdescriptionclass of inhibitor

0.324

Amikacinug/mL Amikacintranslation

0.056

Cap5-10ug/mL Capreomycintranslation

-0.952

Rox10-50 ug/mL Roxithromycintranslation

-0.268

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

2.486

Rif0.2-5ug/mL Rifampicintranscription

-0.255

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.029

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.637

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.025

CPZ10-50 ug/mL Chlorpromazinerespiration

0.074

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.076

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.487

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.342

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.802

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.936

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.047

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.807

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.232

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.369

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.653

Nigericin50 uM Nigericinrespiration

0.021

TRC10-150 ug/mL Triclosanrespiration

-0.826

TRZ10-25 ug/mL Thioridazinerespiration

-0.465

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.214

menadione6-10 ug/mL Menadionerespiration

-0.132

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.322

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.998

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.666

NRP_1Non-replicating persistence stage 1dosRassociated

0.011

Amp0.2mg/mL AmpicillincellWall

-0.643

Cephalexin20-100 ug/mL CephalexincellWall

0.173

Cerulenin0.32-5 ug/mL CerulenincellWall

1.193

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.719

EMB10-20 ug/mL EthambutolcellWall

-0.225

Eta12-40 ug/mL EthionamidecellWall

-0.486

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.603

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.478

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.487

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.061

BZA0.12 mg/mL BenzamidearomaticAmides

0.381

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.134

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.447

H2O24 mM hydrogen peroxideDNAdamaging

0.155

Levo10 ug/mL LevofloxacinDNAdamaging

0.510

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.048

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.452

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.378

UVUV-irradiationDNAdamaging

0.240

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.369

Antimycin12.5-50 ug/mL Antimycin A?

-0.884

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.038

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.196

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.481

PA8240.2-2 ug/mL PA-824?

-0.408

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.227

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.114

Verapamil50 uM Verapamil?

-0.698

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.030

methoxatin10-20 ug/mL Methoxatin?